IL-6-driven STAT signalling in circulating CD4+ lymphocytes is a marker for early anticitrullinated peptide antibody-negative rheumatoid arthritis-Reference-Cited by-同舟云学术

IL-6-driven STAT signalling in circulating CD4+ lymphocytes is a marker for early anticitrullinated peptide antibody-negative rheumatoid arthritis

Published:2015-02-03 Issue:2 Volume:75 Page:466-473
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Anderson Amy E,Pratt Arthur G,Sedhom Mamdouh A K,Doran John Paul,Routledge Christine,Hargreaves Ben,Brown Philip M,Lê Cao Kim-Anh,Isaacs John D,Thomas Ranjeny

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference35 articles.

1. The clinical utility of a rule for predicting rheumatoid arthritis in patients with early undifferentiated arthritis: comment on the article by van der Helm-van Mil et al.[comment];Pratt;Arthritis Rheum,2009

2. A CD4T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly in anti-citrullinated peptide antibody-negative disease;Pratt;Ann Rheum Dis,2012

3. The response of T cells to interleukin-6 is differentially regulated by the microenvironment of the rheumatoid synovial fluid and tissue;Hidalgo;Arthritis Rheum,2012

4. Although IL-6 trans-signaling is sufficient to drive local immune responses, classical IL-6 signaling is obligate for the induction of T cell-mediated autoimmunity;Lissilaa;J Immunol,2012

5. IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial.[Erratum appears in Ann Rheum Dis 2009;68:296];Emery;Ann Rheum Dis,2008

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JAK/STAT signaling in rheumatoid arthritis leukocytes is uncoupled from serum cytokines in a subset of patients;Clinical Immunology;2024-07

2. Monitoring immunE DysregulAtion foLLowing Immune checkpOint-inhibitioN (MEDALLION): protocol for an observational cancer immunotherapy cohort study;BMC Cancer;2024-06-14

3. PIM Kinases as Potential Biomarkers and Therapeutic Targets in Inflammatory Arthritides;International Journal of Molecular Sciences;2024-03-08

4. Th17/1 and ex-Th17 cells are detected in patients with polyarticular juvenile arthritis and increase following treatment;Pediatric Rheumatology;2024-03-02

5. Postbiotic Bioactive Packaging Systems: A Review;Current Nutrition & Food Science;2024-03